Variceal Bleeding Explained: Pathophysiology, Clinical Features and Management Principles
Variceal bleeding is a life-threatening complication of portal hypertension. It occurs when dilated portosystemic collateral veins — most commonly in the distal esophagus — rupture and cause upper gastrointestinal bleeding.
Dr. Seneth Gajasinghe, MBBS, MD Published: 8 June 2026 Updated: 8 June 2026 16 min readReviewed Content
Portal hypertension has two major clinical branches.
The other branch produces portosystemic collaterals, varices and variceal bleeding.
Variceal bleeding is therefore not a separate disease. It is the bleeding complication of portal hypertension — and understanding it requires understanding why portal pressure rises in cirrhosis, which was covered in Portal Hypertension Explained.
Key Concept
Varices form because the portal venous system is trying to bypass the high-resistance cirrhotic liver. This bypass is useful for decompressing portal pressure but dangerous because the collateral veins are thin-walled and carry high-pressure blood.
Identify common sites of portosystemic collaterals
Explain why varices rupture
Recognise clinical features of acute variceal bleeding
Understand the role of endoscopy in diagnosis and treatment
Explain band ligation in simple terms
Distinguish primary from secondary prophylaxis
What Is Variceal Bleeding?
Variceal bleeding is bleeding from dilated portosystemic collateral veins that develop because of portal hypertension.
The most common clinically important site is the distal esophagus, where portal venous blood from the left gastric vein communicates with the azygos system (systemic venous drainage). When these collateral veins enlarge under sustained high pressure, they become esophageal varices.
Variceal bleeding is usually severe because portal venous pressure is high and variceal walls are thin. A single variceal rupture can cause massive haemorrhage with rapid haemodynamic compromise.
Figure 1. Normal esophagus versus variceal esophagus. Dilated submucosal varices are visible as prominent vessels in the distal esophagus, carrying portal blood at high pressure.
Why Do Varices Form?
In cirrhosis, scarring and architectural distortion increase resistance to portal blood flow. Portal pressure rises. The body responds by opening alternative venous channels to bypass the high-resistance liver and return blood to the systemic circulation.
These alternative channels are called portosystemic collaterals. When collaterals form and enlarge at the esophagus or stomach, they are termed varices.
Portal hypertension becomes clinically important when the pressure gradient is high enough to produce complications such as varices, ascites and bleeding.
The hepatic venous pressure gradient (HVPG) is used to estimate portal pressure in specialist settings. Two thresholds are especially important:
HVPG Level
Clinical Meaning
>10 mmHg
Clinically significant portal hypertension. Varices and decompensation become more likely.
>12 mmHg
Bleeding from varices becomes possible. Reducing portal pressure below this level reduces bleeding risk.
Pressure Threshold Pearl
Varices usually form when portal pressure becomes clinically significant. Bleeding risk rises when portal pressure is high enough to overcome the strength of the variceal wall. This is why non-selective beta-blockers, vasoactive drugs and TIPS all work by reducing portal pressure.
Key Teaching Point
Varices are bypass channels. They are physiologically useful — they decompress the portal system — but clinically dangerous because they carry high-pressure portal blood through thin-walled vessels that can rupture. The body's attempt to compensate creates the risk.
Figure 2. From portal hypertension to varices. Rising portal pressure forces the venous system to open collateral channels — which become varices when they enlarge.
Common Sites of Portosystemic Collaterals
Portal hypertension opens collateral pathways wherever portal and systemic venous systems naturally communicate. Four clinically important sites exist:
Site
Portal Tributary
Systemic Drainage
Clinical Result
Distal esophagus
Left gastric vein
Azygos system
Esophageal varices
Stomach
Short gastric veins
Systemic gastric veins
Gastric varices
Rectum
Superior rectal vein
Middle and inferior rectal veins
Rectal varices
Umbilicus
Paraumbilical veins
Superficial abdominal veins
Caput medusae
Exam Pearl
Most important bleeding site = distal esophagus. The left gastric–azygos connection is where clinically significant bleeding most commonly occurs. All four collateral sites are testable, but esophageal varices carry the greatest clinical significance.
Figure 3. Sites of portosystemic collaterals. The distal esophagus is the most clinically important site, but all four locations can develop varices under sustained portal hypertension.
Esophageal vs Gastric Varices
Both esophageal and gastric varices are important, but they differ in frequency, bleeding pattern and management.
Feature
Esophageal Varices
Gastric Varices
Frequency
More common
Less common
Common location
Distal esophagus
Fundus or cardia of stomach
Endoscopic treatment
Band ligation
Often glue injection or specialist therapy
Bleeding pattern
Common, can be massive
Less frequent but often severe
Exam focus
Very high priority
Moderate — know the difference
Figure 4. Esophageal versus gastric varices. Esophageal varices at the gastroesophageal junction are more common and treated with band ligation. Gastric varices require specialist endoscopic or radiological management.
Why Do Varices Rupture?
Varices rupture when wall tension exceeds the structural strength of the variceal wall. Several factors combine to increase rupture risk:
High portal pressure — the driving force transmitting pressure into varices
Large variceal size — wall tension increases as vessel radius increases (Laplace's law)
Thin variceal wall — varices have a thinner wall than normal blood vessels
Red wale marks — longitudinal red streaks visible on endoscopy indicating high rupture risk
Severe liver disease — advanced liver failure worsens portal haemodynamics and reduces the ability to withstand haemorrhage
Rupture Rule
Large varix + high pressure + thin wall = rupture risk. The Laplace relationship means that as a varix enlarges, its wall tension rises disproportionately — small increases in size significantly increase rupture probability.
Red Wale Marks
Red wale marks are longitudinal red streaks on the surface of varices seen on endoscopy. They represent areas of thin epithelium over distended vessels and are an independent predictor of imminent variceal rupture. Their presence escalates the urgency of prophylactic treatment.
Figure 5. Why varices rupture. Wall tension rises with vessel size (Laplace). Combined with high portal pressure, thin walls and red wale marks, the risk of rupture becomes critical.
Risk Factors for First Variceal Bleed
Not all varices bleed. The risk of a first variceal bleed depends on variceal size, endoscopic appearance, portal pressure and severity of liver disease.
Risk Factor
Why It Matters
Large varices
Larger radius increases wall tension, making rupture more likely.
Red wale marks
Endoscopic signs of thin, high-risk areas on the variceal wall.
Severe portal hypertension
Higher pressure increases variceal wall tension and rupture risk.
Advanced cirrhosis
Poor liver reserve increases bleeding risk and worsens outcome after bleeding.
Active alcohol use
May worsen portal pressure, liver inflammation and adherence to prophylaxis.
Exam Tip
The three highest-yield predictors of first variceal bleed are large varices, red wale marks, and advanced liver disease.
Figure 6. Red wale marks and first bleed risk. Large varices with red wale marks have the highest risk of rupture.
Clinical Presentation
Variceal bleeding is an upper gastrointestinal bleeding emergency. The presentation reflects both the site of bleeding and the underlying severity of liver disease.
Haematemesis — vomiting of fresh red blood or altered blood (coffee grounds)
Melaena — black tarry stools from digested upper GI blood
Postural dizziness — reflects significant blood loss and hypovolaemia
Features of chronic liver disease — jaundice, spider naevi, leukonychia, ascites, splenomegaly
Critical Clinical Rule
In a patient with cirrhosis presenting with haematemesis, variceal bleeding must be assumed until proven otherwise by endoscopy. Resuscitation and urgent endoscopic assessment should not be delayed while waiting for other investigations.
Diagnosis
Upper gastrointestinal endoscopy (OGD) is the key diagnostic and therapeutic investigation. It should be performed urgently — usually within 12 hours of presentation, or immediately if there is haemodynamic instability.
Endoscopy identifies:
Source of bleeding — confirms varices are responsible (versus peptic ulcer, Mallory-Weiss tear, etc.)
Size of varices — small, medium or large
Red wale marks — high rupture-risk stigmata
Active bleeding or recent stigmata — confirms active haemorrhage
Need for endoscopic therapy — allows immediate band ligation
Key Principle
Endoscopy is both diagnostic and therapeutic. In the same procedure, the diagnosis is confirmed and band ligation can be performed. This dual role makes urgent endoscopy essential in any suspected variceal bleed.
Acute Management Principles
Acute variceal bleeding management has three parallel goals: stabilise the patient, reduce portal pressure, and control the bleeding source.
1ABC resuscitation — airway protection (especially in encephalopathic patients), IV access, fluid resuscitation.
2Restrictive transfusion strategy — transfuse to haemoglobin of 70–80 g/L. Over-transfusion raises portal pressure and increases rebleeding risk.
3Vasoactive drug — terlipressin or somatostatin analogues (e.g. octreotide) reduce portal pressure, constrict splanchnic vasculature, and reduce variceal blood flow. Start before endoscopy.
4Antibiotic prophylaxis — given to all cirrhotic patients with GI bleeding. Reduces bacterial infection, SBP risk, and rebleeding. Quinolones or cephalosporins are typically used.
5Urgent endoscopy — confirms diagnosis and allows direct haemostatic therapy. Target within 12 hours of presentation.
6Band ligation — first-line endoscopic therapy for active esophageal variceal bleeding. Immediate haemostasis in most cases.
Exam Tip
Three key concepts always tested: (1) vasoactive drugs reduce portal pressure before endoscopy, (2) antibiotics are mandatory in all GI bleeding in cirrhosis, (3) restrictive transfusion strategy — not liberal transfusion — is the evidence-based approach.
Figure 7. Acute variceal bleeding management overview. Resuscitation, pharmacological portal pressure reduction, antibiotic prophylaxis, and urgent endoscopic band ligation form the integrated treatment strategy.
Band Ligation Explained
Endoscopic variceal band ligation (EVL) places small rubber bands around varices through the endoscope. It is the first-line endoscopic therapy for bleeding esophageal varices.
How band ligation works — step by step
Endoscope advances to varix
↓ Varix suctioned into a cap attached to the scope tip
↓ Rubber band deployed around the base of the varix
↓ Varix strangulated — blood flow cut off
↓ Varix thromboses over the following days
↓ Varix sloughs off, leaving a superficial ulcer that heals
↓ Bleeding controlled
Multiple bands may be placed in a single session. Sessions are typically repeated every 2–4 weeks until varices are eradicated. Band ligation is both a haemostatic and prophylactic procedure — it is used acutely to control bleeding and electively to eradicate varices and prevent future bleeds.
Band Ligation vs Sclerotherapy
Endoscopic variceal ligation (EVL) has largely replaced injection sclerotherapy as the preferred endoscopic technique. EVL has fewer complications, lower rebleeding rates and better variceal eradication. Know that sclerotherapy exists as an alternative but EVL is now standard.
What If Bleeding Cannot Be Controlled?
Most esophageal variceal bleeds can be controlled with vasoactive drugs and endoscopic band ligation. However, some patients continue to bleed or rebleed early despite standard therapy.
In that situation, rescue therapy is needed. The goal is to temporarily control haemorrhage and reduce portal pressure more definitively.
TIPS stands for Transjugular Intrahepatic Portosystemic Shunt. It creates an artificial channel between the portal vein and hepatic vein inside the liver. This diverts blood away from the high-pressure portal system, lowers portal pressure and reduces variceal bleeding risk. TIPS is used for uncontrolled or recurrent variceal bleeding when standard therapy is insufficient.
Figure 8. Rescue therapy for uncontrolled variceal bleeding. Balloon tamponade or covered stent may act as a bridge, while TIPS provides portal decompression.
Primary vs Secondary Prophylaxis
Type
When Given
Aim
Primary prophylaxis
Varices present but no previous variceal bleed
Prevent the first bleed
Secondary prophylaxis
After a variceal bleed has occurred
Prevent recurrent bleeding
Primary Prophylaxis
Patients with medium or large varices on endoscopy, or varices with red wale marks, are at significant risk of a first bleed. Non-selective beta-blockers (e.g. propranolol, carvedilol) reduce portal pressure by reducing cardiac output and splanchnic blood flow. Band ligation is an alternative for patients who cannot tolerate beta-blockers.
Secondary Prophylaxis
After a variceal bleed, rebleeding risk is high — historically up to 60–70% without prophylaxis. Secondary prophylaxis combines non-selective beta-blockers with repeated band ligation sessions until varices are eradicated. This combination is more effective than either alone.
Exam Tip
Secondary prophylaxis is the highest-yield prophylaxis concept. After a first variceal bleed, always start non-selective beta-blocker + band ligation. Remember: non-selective (not cardioselective) beta-blockers are needed because splanchnic vasoconstriction requires beta-2 blockade.
Figure 9. Primary versus secondary prophylaxis. Primary prevents the first bleed; secondary prevents recurrence after a bleed has occurred. Both are important but secondary prophylaxis carries the highest urgency.
Prognosis
Variceal bleeding indicates clinically significant portal hypertension and advanced liver disease. Mortality depends on several factors:
Severity of underlying liver disease (Child-Pugh class, MELD score)
Haemodynamic status at presentation — shock worsens outcomes
Early rebleeding within the first five days
Bacterial infection — including SBP precipitated by the bleed
Renal dysfunction — including hepatorenal syndrome
Interaction with Other Complications
Variceal bleeding, SBP and HRS often interact. GI bleeding precipitates bacterial infection — which is why antibiotic prophylaxis is mandatory. Infection and haemorrhage together worsen circulatory dysfunction and increase the risk of hepatorenal syndrome. This interconnection explains why managing cirrhosis requires attention to all complications simultaneously.
Figure 10. Outcomes of variceal bleeding. Early treatment controls bleeding and prevents complications, while delayed or failed control may lead to shock, infection, hepatorenal syndrome and death.
One-Minute Variceal Bleeding Revision
Portal hypertension↓Portosystemic collaterals↓Esophageal varices↓Rupture → haematemesis↓Resuscitation + vasoactive drug + antibiotics↓Urgent endoscopy + band ligation↓Secondary prophylaxis
Figure 11. One-minute variceal bleeding revision: from portal hypertension to collateral formation, rupture, emergency management, and prophylaxis.
High-Yield Exam Pearls
Quick Memory Pattern
Varices = portosystemic collaterals
Most common site = distal esophagus (left gastric → azygos)
Varices form because portal blood bypasses the cirrhotic liver
Large varices bleed more — wall tension increases with radius
Red wale marks = high rupture risk
OGD = diagnostic AND therapeutic
Band ligation = first-line for esophageal varices
Antibiotics mandatory in all GI bleeding in cirrhosis
Restrictive transfusion — not liberal
Secondary prophylaxis = beta-blocker + band ligation
Exam Tips — Variceal Bleeding
Varices are bypass channels — not pathological growths. They form because portal blood is trying to return to the systemic circulation.
Red wale marks — know what they are, what they predict, and that they are seen on endoscopy.
Vasoactive drugs before endoscopy — terlipressin or octreotide should be started as soon as variceal bleeding is suspected, before endoscopy.
Antibiotics are mandatory — all cirrhotic patients with GI bleeding, regardless of clinical signs of infection.
Band ligation strangulates varices, stops blood flow, and causes thrombosis and fibrosis
Primary prophylaxis prevents the first bleed; secondary prophylaxis prevents rebleeding
Secondary prophylaxis = non-selective beta-blocker combined with band ligation sessions
Variceal bleeding precipitates infection and can trigger hepatorenal syndrome
Prognosis depends on severity of liver disease, haemodynamic status, and early rebleeding
Frequently Asked Questions
What causes variceal bleeding?+
Variceal bleeding is caused by rupture of dilated portosystemic collateral veins — varices — that develop because of portal hypertension. In cirrhosis, scarring increases resistance to portal blood flow, raising portal pressure. The body opens collateral channels to bypass the liver. When these channels enlarge at the esophagus or stomach, they become varices carrying high-pressure blood through thin walls — a combination that can cause massive haemorrhage when they rupture.
Why do varices form in portal hypertension?+
Varices form because portal hypertension raises the pressure in the portal venous system. The body responds by opening collateral venous channels at sites where portal and systemic veins naturally communicate — particularly the distal esophagus, stomach, rectum and umbilicus. These collaterals enlarge progressively under sustained high pressure, becoming varices. They are essentially the venous system's attempt to decompress the portal circulation by bypassing the high-resistance cirrhotic liver.
What is clinically significant portal hypertension?+
Clinically significant portal hypertension means portal pressure is high enough to cause complications such as varices, ascites or decompensation. In specialist practice, it is often defined by a hepatic venous pressure gradient (HVPG) above 10 mmHg. Variceal bleeding becomes more likely when HVPG exceeds about 12 mmHg. This is why treatments that reduce portal pressure — such as non-selective beta-blockers, vasoactive drugs and TIPS — reduce bleeding risk.
Why do varices rupture?+
Varices rupture when wall tension exceeds the structural strength of the variceal wall. According to Laplace's law, wall tension increases as vessel radius increases — so larger varices are under greater mechanical stress. Combined with high intraluminal portal pressure and a thin variceal wall, rupture risk becomes significant. Red wale marks on endoscopy are superficial mucosal changes indicating areas of particularly thin and vulnerable wall, representing the highest-risk lesions.
What are red wale marks?+
Red wale marks are longitudinal red streaks on the surface of varices seen on upper GI endoscopy. They represent areas of particularly thin epithelium overlying distended, high-pressure variceal vessels. Red wale marks are an important endoscopic predictor of imminent variceal rupture and significantly increase the urgency of prophylactic treatment. Their presence on medium or large varices is an indication for primary prophylaxis even before a bleed has occurred.
Why is variceal bleeding dangerous?+
Variceal bleeding is dangerous for several reasons: portal venous pressure is high, so bleeding is often rapid and massive; patients with cirrhosis already have impaired coagulation from reduced hepatic synthesis of clotting factors; haemorrhage precipitates bacterial infection, worsening circulatory dysfunction; bleeding can trigger hepatic encephalopathy; and the stress of haemorrhage can precipitate hepatorenal syndrome. Mortality from acute variceal bleeding remains significant, particularly in patients with advanced liver disease.
What is band ligation?+
Endoscopic variceal band ligation (EVL) is the first-line endoscopic therapy for esophageal varices. The procedure uses an endoscope fitted with a cap containing pre-loaded rubber bands. Each varix is suctioned into the cap and a rubber band is deployed around its base, strangulating it. The varix thromboses and scleroses over several days, then sloughs off, leaving a superficial ulcer that heals. Sessions are repeated every 2–4 weeks until all varices are eradicated. EVL is used both to treat active bleeding and to prevent future bleeds.
What is the difference between esophageal and gastric varices?+
Esophageal varices form at the distal esophagus via the left gastric–azygos venous connection. They are more common and are the primary target of endoscopic band ligation. Gastric varices form at the gastric fundus or cardia via the short gastric veins and are less common but tend to bleed more severely when they do rupture. Gastric varices are harder to treat endoscopically — they often require tissue adhesive injection (glue), balloon-occluded retrograde transvenous obliteration (BRTO) or TIPS rather than standard band ligation.
Can varices occur without cirrhosis?+
Yes. Varices can occur in any condition causing portal hypertension, not only cirrhosis. Non-cirrhotic causes include portal vein thrombosis, Budd-Chiari syndrome (hepatic vein outflow obstruction), schistosomiasis (a major cause globally), congenital hepatic fibrosis, and myeloproliferative disorders causing portal vein thrombosis. In these patients, liver function may be relatively preserved, so prognosis after variceal bleeding is often better than in cirrhotic patients.
Can variceal bleeding recur?+
Yes — rebleeding risk is very high after a first variceal bleed, historically reported at 60–70% within one year without prophylaxis. Early rebleeding (within five days of the initial bleed) is particularly dangerous and is associated with high short-term mortality. This is why secondary prophylaxis — combining non-selective beta-blockers with repeated band ligation sessions until variceal eradication — is mandatory after any variceal bleed.
What is TIPS in variceal bleeding?+
TIPS stands for Transjugular Intrahepatic Portosystemic Shunt. It is a radiological procedure that creates a channel between the portal vein and hepatic vein inside the liver. This allows portal blood to bypass the high-resistance cirrhotic liver and drain into the systemic circulation, reducing portal pressure. In variceal bleeding, TIPS is used when bleeding cannot be controlled with standard therapy or when there is high risk of early rebleeding.
What is the difference between primary and secondary prophylaxis?+
Primary prophylaxis is given to patients who have varices but have never had a variceal bleed — the aim is to prevent the first bleed. It typically involves non-selective beta-blockers (propranolol or carvedilol) for medium or large varices, with band ligation as an alternative. Secondary prophylaxis is given after a variceal bleed has already occurred — the aim is to prevent recurrence. It combines non-selective beta-blockers with repeated band ligation sessions until variceal eradication. The combination is more effective than either therapy alone.
References
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop. J Hepatol. 2015;63(3):743–752.
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–938.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
Bosch J, Abraldes JG, Berzigotti A, Garcia-Tsao G. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573–582.
Tripathi D, Stanley AJ, Hayes PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–1704.
Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33(5):1060–1064.
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.
Medical Education Disclaimer
This article is intended for medical education only. It is designed for medical students, intern doctors, and junior doctors and does not constitute clinical advice. Always refer to current local guidelines and specialist hepatological input when managing patients with variceal bleeding.